These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 20816021)

  • 61. Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.
    Højberg PV; Zander M; Vilsbøll T; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabetologia; 2008 Apr; 51(4):632-40. PubMed ID: 18292985
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Partial blockade of Kv2.1 channel potentiates GLP-1's insulinotropic effects in islets and reduces its dose required for improving glucose tolerance in type 2 diabetic male mice.
    Sukma Rita R; Dezaki K; Kurashina T; Kakei M; Yada T
    Endocrinology; 2015 Jan; 156(1):114-23. PubMed ID: 25337656
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
    Westberg-Rasmussen S; Starup-Linde J; Hermansen K; Holst JJ; Hartmann B; Vestergaard P; Gregersen S
    Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
    Banerji MA
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus.
    Lastya A; Saraswati MR; Suastika K
    BMC Res Notes; 2014 Nov; 7():849. PubMed ID: 25427660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes.
    Ichikawa R; Takano K; Fujimoto K; Motomiya T; Kobayashi M; Kitamura T; Shichiri M
    Endocr J; 2019 Aug; 66(8):663-675. PubMed ID: 31142688
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes.
    Deane AM; Summers MJ; Zaknic AV; Chapman MJ; Fraser RJ; Di Bartolomeo AE; Wishart JM; Horowitz M
    Crit Care; 2011; 15(1):R35. PubMed ID: 21255422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.
    Chen L; Yao X; Young A; McNulty J; Anderson D; Liu Y; Nystrom C; Croom D; Ross S; Collins J; Rajpal D; Hamlet K; Smith C; Gedulin B
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E68-76. PubMed ID: 21934041
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colonic delivery of docosahexaenoic acid improves impaired glucose tolerance via GLP-1 secretion and suppresses pancreatic islet hyperplasia in diabetic KK-A(y) mice.
    Shida T; Kamei N; Takeda-Morishita M; Isowa K; Takayama K
    Int J Pharm; 2013 Jun; 450(1-2):63-9. PubMed ID: 23618969
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
    Du X; Kosinski JR; Lao J; Shen X; Petrov A; Chicchi GG; Eiermann GJ; Pocai A
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E265-71. PubMed ID: 22621866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes.
    Jiménez A; Mari A; Casamitjana R; Lacy A; Ferrannini E; Vidal J
    Diabetes; 2014 Oct; 63(10):3372-7. PubMed ID: 24848069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).
    Bala M; Martin J; Kopp A; Hanses F; Buechler C; Schäffler A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2493-501. PubMed ID: 21677044
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of GW002, a novel recombinant human glucagon-like peptide-1 (GLP-1) analog fusion protein, on CHO recombinant cells and BKS-db mice.
    Ji WW; Yu DA; Fan M; You M; Lu Y; Li EB; Xie N; Yan SS
    Acta Diabetol; 2017 Jul; 54(7):685-693. PubMed ID: 28424924
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes.
    van der Klauw MM; Wolffenbuttel BH
    Neth J Med; 2012 Dec; 70(10):436-43. PubMed ID: 23230012
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.
    Shimodaira M; Muroya Y; Kumagai N; Tsuzawa K; Honda K
    J Endocrinol Invest; 2013 Oct; 36(9):734-8. PubMed ID: 23580083
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls.
    Zibar K; Ćuća JK; Blaslov K; Bulum T; Smirčić-Duvnjak L
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):220-5. PubMed ID: 25005458
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A bitter herbal medicine Gentiana scabra root extract stimulates glucagon-like peptide-1 secretion and regulates blood glucose in db/db mouse.
    Suh HW; Lee KB; Kim KS; Yang HJ; Choi EK; Shin MH; Park YS; Na YC; Ahn KS; Jang YP; Um JY; Jang HJ
    J Ethnopharmacol; 2015 Aug; 172():219-26. PubMed ID: 26129938
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus.
    Yan P; Li L; Yang M; Liu D; Liu H; Boden G; Yang G
    Diabetes Res Clin Pract; 2011 Jun; 92(3):368-74. PubMed ID: 21458097
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New ways in which GLP-1 can regulate glucose homeostasis.
    D'Alessio DA; Sandoval DA; Seeley RJ
    J Clin Invest; 2005 Dec; 115(12):3406-8. PubMed ID: 16322789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.